Table 3.
Antibiotic resistance pattern for CRBSI
| Pathogens | Antibiotic resistance (% resistance) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||
| PT | CT | CX | CZ | GN | AK | CP | LE | CO | MP | IP | EP | AZ | TP | |
| S. aureus (MSSA)† | - | - | - | - | 0 | - | 100 | 100 | 80 | - | - | - | - | 66.6 |
| P. aeruginosa | 25 | 0 | - | - | 60 | 40 | 100 | 0 | - | 75 | 50 | - | 60 | - |
| K. pneumoniae | 33.3 | 100 | 66.6 | 33.3 | 50 | 50 | - | 66.6 | - | 33.3 | 0 | 50 | 50 | - |
| E. coli | 66.6 | 50 | 100 | - | 66.6 | 33.3 | 100 | - | 66.6 | 66.6 | - | 50 | 100 | - |
| A. baumanii ǂ | - | - | 100 | - | - | 50 | 100 | - | - | 50 | - | - | - | - |
| E. faecalis § | - | - | - | - | 0 | 0 | - | 0 | - | - | - | - | - | 0 |
| B. capacia | - | 0 | - | - | 0 | - | - | 0 | 100 | 0 | - | - | - | - |
| Enterobacter | - | 0 | 0 | - | 0 | 0 | - | - | 100 | 0 | 0 | 0 | 0 | - |
| Overall resistance | 33.3 | 28.5 | 77.7 | 20 | 33.3 | 38.4 | 100 | 30.7 | 66.6 | 50 | 33.3 | 40 | 63.4 | 50 |
PT: Piperacillin-tazobactam, CT: Ceftazidime, CX: Ceftriaxone, CP: Cefoperazone, GN: Gentamicin, AK: Amikacin, CP: Ciprofloxacin, LE: Levofloxacin, CO: Cotrimoxazole, MP: Meropenem, IP: Imipenem, EP: Ertapenem, AZ: Aztreonam, TP: Teicoplanin, † & §: no resistance to Vancomycin and Linezolid, ǂ: No resistance to Colistin